Literature DB >> 21710177

FGF23 analysis of a Chinese family with autosomal dominant hypophosphatemic rickets.

Yue Sun1, Ou Wang, Weibo Xia, Yan Jiang, Mei Li, Xiaoping Xing, Yingying Hu, Huaicheng Liu, Xunwu Meng, Xueying Zhou.   

Abstract

Autosomal dominant hypophosphatemic rickets (ADHR; MIM 193100) is a hereditary disorder characterized by isolated renal phosphate wasting, hypophosphatemia, and inappropriately normal 1,25-dihydroxyvitamin D(3) levels. Recent studies have shown that the fibroblast growth factor 23 (FGF23) gene is responsible for this disease. FGF23 protein is a phosphaturic factor that is elevated in several diseases associated with hypophosphatemia and rickets but varies with disease status in ADHR. In the present study we observed a Chinese family of Han ethnic origin diagnosed with ADHR. The proband is a 30-year-old woman with no history of rickets but with multiple tooth abscesses as a young adult. She presented with progressive painful swelling of the left ankle after a blunt trauma at 26 years of age. She developed back pain, generalized weakness, and fatigue, and she could barely walk at age 27. She was found to have severe hypophosphatemia, low ratio of phosphorus tubule maximum (TmP) to glomerular filtration rate (GFR) (TmP/GFR), and elevated alkaline phosphatase at age 28. Her brother, 26 years old, presented with fatigue at 24 years of age and is normophosphatemic. The parents of this family had no history of rickets or hypophosphatemia. Direct sequence analysis of genomic DNA demonstrated a single heterozygous c.527G>A (p.R176Q) mutation in the FGF23 gene in three family members, including the proband, her brother, and their mother. Intact FGF23 assay of seven time points during the oral phosphate loading test showed no significant relationship between intact FGF23 and serum phosphorus levels of the subject with ADHR and a control. It is probably the first report of a Chinese family with ADHR.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21710177     DOI: 10.1007/s00774-011-0285-5

Source DB:  PubMed          Journal:  J Bone Miner Metab        ISSN: 0914-8779            Impact factor:   2.626


  26 in total

1.  Bone as a source of FGF23: regulation by phosphate?

Authors:  Michiko Mirams; Bruce G Robinson; Rebecca S Mason; Anne E Nelson
Journal:  Bone       Date:  2004-11       Impact factor: 4.398

2.  Loss of renal phosphate wasting in a child with autosomal dominant hypophosphatemic rickets caused by a FGF23 mutation.

Authors:  K Kruse; D Woelfel; T M Strom; T M Storm
Journal:  Horm Res       Date:  2001

3.  The assessment of phosphate reabsorption.

Authors:  O L Bijvoet; D B Morgan; P Fourman
Journal:  Clin Chim Acta       Date:  1969-10       Impact factor: 3.786

4.  Autosomal dominant hypophosphataemic rickets is associated with mutations in FGF23.

Authors: 
Journal:  Nat Genet       Date:  2000-11       Impact factor: 38.330

5.  Autosomal dominant hypophosphatemic rickets/osteomalacia: clinical characterization of a novel renal phosphate-wasting disorder.

Authors:  M J Econs; P T McEnery
Journal:  J Clin Endocrinol Metab       Date:  1997-02       Impact factor: 5.958

6.  [Different forms of clinical presentation of an autosomal dominant hypophosphatemic rickets caused by a FGF23 mutation in one family].

Authors:  Armando Luis Negri; Teresa Negrotti; Guillermo Alonso; Titania Pasqualini
Journal:  Medicina (B Aires)       Date:  2004       Impact factor: 0.653

7.  Serum FGF23 levels in normal and disordered phosphorus homeostasis.

Authors:  Thomas J Weber; Shiguang Liu; Olafur S Indridason; L Darryl Quarles
Journal:  J Bone Miner Res       Date:  2003-07       Impact factor: 6.741

Review 8.  Emerging role of fibroblast growth factor 23 in a bone-kidney axis regulating systemic phosphate homeostasis and extracellular matrix mineralization.

Authors:  Shiguang Liu; Aditi Gupta; L Darryl Quarles
Journal:  Curr Opin Nephrol Hypertens       Date:  2007-07       Impact factor: 2.894

Review 9.  Hypophosphatemia: the common denominator of all rickets.

Authors:  Dov Tiosano; Ze'ev Hochberg
Journal:  J Bone Miner Metab       Date:  2009-06-06       Impact factor: 2.626

10.  Three novel mutations of the PHEX gene in three Chinese families with X-linked dominant hypophosphatemic rickets.

Authors:  Weibo Xia; Xunwu Meng; Yan Jiang; Mei Li; Xiaoping Xing; Li Pang; Ou Wang; Yu Pei; Li-Yun Yu; Yue Sun; Yingying Hu; Xueying Zhou
Journal:  Calcif Tissue Int       Date:  2007-11-29       Impact factor: 4.333

View more
  8 in total

Review 1.  FGF23 and Phosphate Wasting Disorders.

Authors:  Xianglan Huang; Yan Jiang; Weibo Xia
Journal:  Bone Res       Date:  2013-06-28       Impact factor: 13.567

Review 2.  The rachitic tooth.

Authors:  Brian L Foster; Francisco H Nociti; Martha J Somerman
Journal:  Endocr Rev       Date:  2013-12-04       Impact factor: 19.871

Review 3.  Can features of phosphate toxicity appear in normophosphatemia?

Authors:  Satoko Osuka; Mohammed S Razzaque
Journal:  J Bone Miner Metab       Date:  2012-01-05       Impact factor: 2.626

Review 4.  FGF23 and Associated Disorders of Phosphate Wasting.

Authors:  Anisha Gohil; Erik A Imel
Journal:  Pediatr Endocrinol Rev       Date:  2019-09

Review 5.  Hypophosphatemia and growth.

Authors:  Fernando Santos; Rocío Fuente; Natalia Mejia; Laura Mantecon; Helena Gil-Peña; Flor A Ordoñez
Journal:  Pediatr Nephrol       Date:  2012-11-22       Impact factor: 3.714

6.  Autosomal dominant hypophosphatemic rickets in an 85 year old woman: characterization of her disease from infancy through adulthood.

Authors:  Margaret Seton; Harald Jüppner
Journal:  Bone       Date:  2012-11-19       Impact factor: 4.398

7.  Molecular Diagnoses of X-Linked and Other Genetic Hypophosphatemias: Results From a Sponsored Genetic Testing Program.

Authors:  Eric T Rush; Britt Johnson; Swaroop Aradhya; Daniel Beltran; Sara L Bristow; Scott Eisenbeis; Norma E Guerra; Stan Krolczyk; Nicole Miller; Ana Morales; Prameela Ramesan; Soodabeh Sarafrazi; Rebecca Truty; Kathryn Dahir
Journal:  J Bone Miner Res       Date:  2021-11-10       Impact factor: 6.390

Review 8.  Fibroblast Growth Factor 2 and Its Receptors in Bone Biology and Disease.

Authors:  J Douglas Coffin; Collin Homer-Bouthiette; Marja Marie Hurley
Journal:  J Endocr Soc       Date:  2018-05-28
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.